Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues

Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP2019) is organized by Global Education Group and will be held on Oct 04, 2019 at Hilton Denver Inverness, Englewood, Colorado, United States of America.

Target Audience:
This educational activity is designed to meet the needs of primary care practitioners inclusive of: physicians, nurse practitioners, physician assistants, and pharmacists who have interest in the emerging field of cannabis.

Accreditation:
Global Education Group designates this live CME activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

This activity is approved for 2 COPIC Points.

Global Education Group designates this continuing education activity for 7.5 contact hour(s) (0.75 CEUs) of the Accreditation Council for Pharmacy Education. 

Description:
Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP2019) is an educational and accredited CME/CE live activity which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policy and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry.

This symposium is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medicinal cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.

Overall, the participants of Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP2019) will benefit from learning about recent and emerging clinical practices involving the endocannabinoid system.

Regardless of your role in the medical community, this symposium is for you!

Learning Objectives:
After completing this activity, participants should be able to
1. Outline the endocannabinoid system.
2. Review the current evidence-based indications for the use of cannabis.
3. Review the effects of cannabis use, including physiological effects.
4. Describe the Colorado experience after mass commercialization of cannabis for medical purposes.
5. Review Colorado Medical Board Rules, Regulations and Policies impact on cannabinoid use.
6. Recognize FDA policy and regulation of CBD-containing products for therapeutic use.
7. Explain the interaction of cannabis and opioids.
8. Review the known risks for psychiatric complications related to cannabinoid use.
9. Discuss recent studies of cannabinoids in the treatment of psychiatric disorders.
10. Discuss what is known about cannabinoid exposure in developing brains.
11. Identify major epidemiological trends associated with cannabis legalization.
12. Describe common emergency department presentations related to cannabis use.
13. Identify best practices for discussing cannabinoid use in Colorado’s legal and regulatory climate.